# Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** Global Blood Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001629137

## About

Global Blood Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001629137, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-02-23, it reported annual revenue of USD 194,749,000; net income of USD -303,091,000; total assets of USD 939,208,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $194.7M (USD 194,749,000)
- **Net income:** -$303.1M (USD -303,091,000)
- **Total assets:** $939.2M (USD 939,208,000)
- **Cash and equivalents:** $684.7M (USD 684,717,000)
- **Operating cash flow:** -$256.8M (USD -256,813,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $123.8M (USD 123,803,000)
- **Net income:** -$247.6M (USD -247,553,000)
- **Total assets:** $724.0M (USD 724,002,000)
- **Cash and equivalents:** $494.8M (USD 494,766,000)
- **Operating cash flow:** -$211.9M (USD -211,862,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $2.1M (USD 2,108,000)
- **Net income:** -$266.8M (USD -266,766,000)
- **Total assets:** $796.1M (USD 796,099,000)
- **Cash and equivalents:** $302.2M (USD 302,237,000)
- **Operating cash flow:** -$194.4M (USD -194,417,000)

### FY2018 (period ended 2018-12-31)

- **Net income:** -$174.2M (USD -174,193,000)
- **Total assets:** $617.6M (USD 617,643,000)
- **Cash and equivalents:** $275.4M (USD 275,357,000)
- **Operating cash flow:** -$135.4M (USD -135,375,000)

## Recent SEC filings

- Form 8-K — filed 2022-10-05 — period 2022-10-05 — CURRENT REPORT
- Form 8-K — filed 2022-09-30 — period 2022-09-30 — CURRENT REPORT
- Form 8-K — filed 2022-09-23 — period 2022-09-23 — CURRENT REPORT
- Form 10-Q — filed 2022-08-08 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-08-08 — period 2022-08-07 — CURRENT REPORT
- Form 8-K — filed 2022-07-26 — period 2022-07-26 — FORM 8-K
- Form 8-K — filed 2022-07-14 — period 2022-07-14 — FORM 8-K
- Form 8-K — filed 2022-06-29 — period 2022-06-29 — FORM 8-K
- Form SC 13G — filed 2022-06-17
- Form 8-K — filed 2022-06-15 — period 2022-06-14 — 8-K
- Form 8-K — filed 2022-06-13 — period 2022-06-13 — FORM 8-K
- Form 8-K — filed 2022-06-10 — period 2022-06-10 — FORM 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/global-blood-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology